Resistance Mutations Against HCV Protease Inhibitors and Antiviral Drug Design

By  

Current Pharmaceutical Design, Vol. 20, Iss. 5, 2014-02 ,pp. : 694-703

Bentham Science Publishers

Access to resources Recommend Favorite

Antituberculosis drug resistance: new global data on an emerging global emergency

By Chapman Ann LN  

Clinical Medicine, Vol. 8, Iss. 5, 2008-10 ,pp. : 478-479

Royal College Of Physicians

Access to resources Recommend Favorite

Editorial (Hot Topic: Network Pharmacology: An Emerging Field in Cancer Drug Discovery)

By  

Current Drug Discovery Technologies, Vol. 10, Iss. 2, 2013-06 ,pp. : 93-94

Bentham Science Publishers

Access to resources Recommend Favorite

Resistance of HBV and HCV to antiviral therapies

By Polyak Stephen J  

Future Virology, Vol. 3, Iss. 3, 2008-05 ,pp. : 221-224

Future Medicine

Access to resources Recommend Favorite

Drug treatment programs' HCV service delivery to their HCV positive clients*

By Astone-Twerell Janetta M.   Strauss Shiela M.   Hagan Holly   Des Jarlais Don C.  

Addiction Research and Theory, Vol. 14, Iss. 3, 2006-06 ,pp. : 289-302

Informa Healthcare

Access to resources Recommend Favorite